Slika na naslovnici

Use of unlicensed drugs and off-label drug use: focus on COVID-19

Introduction. In a crisis, like the COVID-19 outbreak, the strategy of experimental drug use in clinical practice increases the availability of potentially effective drugs that have not yet proven the opposite for patients with life-threatening diseases, despite the fact that such use is «off-label»...

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	S. A. Mishinova (Author), A. A. Zhuravkov (Author), V. K. Zhuravko (Author)
Format:	Knjiga
Izdano:	Izdatelstvo OKI, 2020-10-01T00:00:00Z.
Teme:	article
Online dostop:	Connect to this object online.
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Unlicensed and off-label drug use in paediatric wards
od: Suhair Moayid Rasheed
Izdano: (2010)

Off-label and unlicensed drugs in neonatology
od: Segundo Rite-Gracia, et al.
Izdano: (2021)

EXTENT OF UNLICENSED AND OFF-LABEL DRUG USE IN THE PEDIATRIC PRACTICE OF SMOLENSK
od: S.A. Rachina, et al.
Izdano: (2010)

EXTENT OF UNLICENSED AND OFF-LABEL DRUG USE IN THE PEDIATRIC PRACTICE OF SMOLENSK
od: S.A. Rachina, et al.
Izdano: (2010)

Drug utilization in neonatal setting of Pakistan: focus on unlicensed and off label drug prescribing
od: Muhammad Aamir, et al.
Izdano: (2018)

Use of unlicensed and off-label drugs in neonates in a Brazilian university hospital
od: Adriana Cristina de Souza Gonçalves, et al.
Izdano: (2018)

Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran
od: Leila Kouti, et al.
Izdano: (2019)

Quality use of an unlicensed medicine and off label use of a medicine
od: Vasilka Nicha, et al.
Izdano: (2014)

Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit
od: Meles Tekie Gidey, et al.
Izdano: (2020)

Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: a systematic review
od: Fábio Reis, et al.
Izdano: (2021)

Accuracy of Dose Administered to Children Using Off-Labelled or Unlicensed Oral Dosage Forms
od: Guillaume Binson, et al.
Izdano: (2021)

O enigma do uso de medicamentos off-label e não licenciados na neonatologia The conundrum of off-label and unlicensed drug usage in neonatology
od: Lucky Jain
Izdano: (2012)

Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines
od: Haline Tereza Matias Lima Costa, et al.
Izdano: (2021)

Exploratory Findings of Prescribing Unlicensed and Off-Label Medicines Among Children and Neonates
od: Shakeel S, et al.
Izdano: (2020)

Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit
od: Laura Goedel dos Santos, et al.
Izdano: (2023)

Off-Label Drug Use in Pediatric Practice: Unsolved Problems
od: A. R. Titova, et al.
Izdano: (2015)

A Survey of Off-label and Unlicensed Antibiotic and Respiratory Medications Prescribed for Toddler Patients
od: Ali Soochi, et al.
Izdano: (2022)

Utilisation of drugs for the treatment of psychiatric diseases in the pediatric population: focus on off-label use
od: Stella Pesiou, et al.
Izdano: (2023)

Drug use in off-label dosage regimes
od: Roberto Lozano Ortiz
Izdano: (2015)

The problem of off label drug use in pediatrics: pediatricians and parents survey results
od: E. A. Mardganieva, et al.
Izdano: (2018)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
od: Weilan Wang, et al.
Izdano: (2013)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China.
od: Weilan Wang, et al.
Izdano: (2013)

Recommendations on Off-Label Drug Use in Pediatric Guidelines
od: Min Meng, et al.
Izdano: (2022)

Use of off-label drugs in neonatal intensive care
od: Andrea Sucasas Alonso, et al.
Izdano: (2019)

Off-label drugs use in pediatric palliative care
od: Lucia De Zen, et al.
Izdano: (2018)

The Russian study of «off-label» drug use in pediatric practice: 2015 vs 2012
od: A. R. Titova, et al.
Izdano: (2018)

Off-label drug in the newborn
od: Laura Cuzzolin
Izdano: (2014)

Off-label use of oncology drugs: national survey results
od: Eva González-Haba Peña, et al.
Izdano: (2015)

Uso de medicamentos off-label e não licenciados em unidade de tratamento intensivo neonatal e sua associação com escores de gravidade Use of off-label and unlicensed drugs in the neonatal intensive care unit and its association with severity scores
od: Clarissa G. Carvalho, et al.
Izdano: (2012)

Off-label prescription of drugs at hospital
od: Vicente Arocas Casañ, et al.
Izdano: (2016)

OFF-LABEL PEDIATRIC DRUG USE IN INDONESIA : A SYSTEMATIC REVIEW
od: Dewi Latifatul Ilma, et al.
Izdano: (2020)

The evolving role and utility of off-label drug use in multiple myeloma
od: James H Stoeckle, et al.
Izdano: (2021)

Guideline for the management of pediatric off-label use of drugs in China (2021)
od: Min Meng, et al.
Izdano: (2022)

Judicial and legislative practice and related suggestions on off-label drug use in China
od: Wenjie Si, et al.
Izdano: (2023)

"Off-label" drugs: legal problems and socio-economic aspects of application practice
od: S. V. Russkikh, et al.
Izdano: (2023)

High Prevalence of Potential Drug-Drug Interactions Among Patients Treated with Off-label Therapies for COVID-19
od: Allan Ramos-Esquivel, et al.
Izdano: (2022)

Off-label use of drugs administered by enteral feeding tubes in an Intensive Care Unit in Fortaleza, Brazil
od: Gabriela A. ABREU, et al.
Izdano: (2021)

Use of off-label drugs and the prevalence of adverse reaction to drugs in the adult intensive care unit of a Brazilian public hospital
od: Lívia P. MOREIRA, et al.
Izdano: (2023)

A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic
od: Matteo Bassetti, et al.
Izdano: (2020)

Retrospective analysis of reports on psychopharmaceuticals drugs safety to identify cases of off-label
od: E. O. Zhuravleva, et al.
Izdano: (2022)